Industry news

• Artificial intelligence may influence whether you can get pain medication

  01 September 2023 Andy Miller and Sam Whitehead, KFF Health News / FiercePharma

  Tools like Narx Scores are used to help medical providers review controlled substance prescriptions. They influence, and can limit, the prescribing of painkillers, similar to a credit score influencing the terms of a loan. Narx Scores and an algorithm-generated overdose risk rating are produced by healthcare technology company Bamboo Health (formerly Appriss Health) in its NarxCare platform.

• NEWS CGT manufacturing QC market to value $2.8b by 2031

  01 September 2023 Catherine Eckford / European Pharmaceutical Review

  Advanced analytical technologies in quality control (QC) processes in cell and gene therapy manufacturing is anticipated to help deliver a 24.6 percent market CAGR between 2023 and 2031.

• The price for the second Russian generic version of lapatinib has been settled

  31 August 2023 GxPNews

  The Federal Antimonopoly Service of Russia settled the prices of Lapatinib-Promomed, the second generic drug with the active ingredient lapatinib. A package of 140 tablets will be priced at 50% less than the foreign reference drug Tyverb, which costs 107,090 rubles. The cost will be significantly reduced to 53,545 rubles.

• Withings’ ECG-equipped smart scale earns FDA clearance for afib detection

  31 August 2023 Andrea Park / FiercePharma

  In recent years, electrocardiogram technology has become increasingly widely available, embedded into dedicated portable devices, smartwatches and, now, even bathroom scales.

• The production of Russian BAA supplements increased by 17%

  30 August 2023 GxPNews

  The production of biologically active food supplements in Russia is experiencing significant growth, as reported by the Federal State Statistics Service, also known as Rosstat. In just seven months of 2023, 12.2 thousand tons of BAA product were manufactured, which is 17.1% more than in the same period last year.

• The network of Russian 24-hour pharmacies may be expanded

  30 August 2023 GxPNews

  On the portal for posting public initiatives of citizens of the Russian Federation, a proposal has appeared to increase the network of round-the-clock pharmacies. According to the authors of the initiative, points of uninterrupted sale of medicines should be present in every locality with three to five thousand inhabitants.

• Pharmaceutical migration study sampling procedure reported

  29 August 2023 Catherine Eckford / European Pharmaceutical Review

  A study incorporating new methodologies has described a stratified sampling procedure used for analyte response evaluation in pharmaceutical migration studies.

• Russia conducts preclinical studies of mRNA vaccine against TB

  29 August 2023 GxPNews

  The Scientific Center for Translational Medicine at Sirius University revealed the preliminary results of their preclinical trials for a revolutionary multi-epitope mRNA vaccine against tuberculosis. The press service of the educational center reports that, during the research conducted on rodents, the drug demonstrated remarkable effectiveness.

• The production volume of finished drugs in 2023 soared to 398.6 billion rubles

  28 August 2023 GxPNews

  The analytical company RNC Pharma provided information on the activity of the production of medicines in Russia in July 2023. The total monetary volume of finished drugs production showed a long-term dynamics at the level of 17%. The company notes that “so far this is an absolute record not only for the current year, but also for the last 14 months.”

• The State Scientific Center “Vector” plans to construct a dedicated facility designed to handle highly hazardous viruses

  28 August 2023 GxPNews

  The commencement of construction is scheduled for 2027. The establishment of this facility will greatly accelerate the development of antiviral drugs. According to Anastasia Gladysheva, a senior researcher at the State Scientific Center, Vector is one of the few organizations that possess the necessary level of biological protection. This permits the center to effectively and securely handle highly hazardous viruses.